Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to ...

Enliven Therapeutics (ELVN) jumped on strong ELVN-001 phase 1b CML data, but a rich valuation may cap upside—get the latest ...

A practical AI workflow for creating social video variations—using generation to explore ideas and face swap without ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with the Cancer Research Institute (CRI) to advance the frontiers of immuno-oncology through ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Commercial nuclear reactors all work pretty much the same way. Atoms of a radioactive material split, emitting neutrons.

Definium’s late-stage pipeline includes four Phase 3 trials—two each for GAD and MDD—anchored by its lead candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD.

The number of STPs found to be failing on treatment norms has increased with nine such plants earmarked by the DPCC in ...

Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...

The ongoing Special Intensive Revision of electoral rolls in West Bengal has seen the deletion of about 58 lakh names. Our ...